Problem Based Learning in HBV: A Patient Simulation for Improving Treatment Decisions and Long-Term CarePremiere Date: Friday, July 28, 2017
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Saturday, July 28, 2018
Note: Credit Is No Longer Available
|Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF, FAASLD,
Director, Liver Care Network and Organ Care Research
Swedish Medical Center
|Su Wang, MD, MPH
Medical Director, Chinese Medical Program
Center for Asian Health
Saint Barnabas Medical Center
West Orange, NJ
Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States despite the availability of screening guidelines and prophylactic vaccines. Chronic HBV infection causes severe complications, including cirrhosis and hepatocellular carcinoma in 20% - 30% of patients. As a result, HBV infection is the most common reason for liver transplantation.1
While recommendations exist, primary care providers are not adequately screening at-risk patients for HBV infection and many adults remain undiagnosed. Once identified, linking HBV patients from community clinics to proper care requires that clinicians be aware of optimal treatment plans based on lab results.
In this CME Outfitters decision-tree medical simulation participants will navigate the clinical challenges presented by HBV. Along the way, expert faculty will provide guidance, insights, and evidence for the positive and negative consequences of their decisions. This actionable, evidence-based simulation will improve clinician confidence in their ability to recognize and assess patients with HBV and develop personalized treatment plans for managing their patients.
Reference: U.S. Department of Health and Human Services [HHS]. Action plan for the prevention, care, & treatment of viral hepatitis 2014-2016. HHS Website. http://aids.gov/pdf/viral-hepatitis-action-plan.pdf.
At the end of this CE activity, participants should be able to:
- Increase the rate at which clinicians appropriately screen at-risk patients for HBV.
- Develop a comprehensive long-term management strategy for patients who test positive for HBV to ensure they are monitored and receive optimal care.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Explain how to appropriately screen at-risk patients for HBV.
- Identify a treatment strategy for patients who test positive for HBV to ensure they are referred and monitored for optimal care.
Supported by an educational grant from Gilead Sciences, Inc.
Internists, subspecialists, primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1 contact hour
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1 contact hours of pharmacotherapeutic contact hours.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.10 CEUs) Universal Activity Number:
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, have evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Kowdley has nothing to disclose.
Dr. Wang has nothing to disclose.
Jeffrey Helfand, DO, MS (peer reviewer) has nothing to disclose.
Kimberley Murray, RN, MS (peer reviewer) has nothing to disclose.
Kashemi D. Rorie, PhD (planning committee) has nothing to disclose.
Sharon Tordoff, CHCP (planning committee) has nothing to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to disclose.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).